Cara D Varley

One-year acyclovir prophylaxis for preventing varicella-zoster virus disease after hematopoietic cell transplantation: no evidence of rebound varicella-zoster virus disease after drug discontinuation

Véronique Erard, Katherine A. Guthrie, Cara D Varley et al. · Blood · 2007 · 190 citations · Full text

Safety and Tolerability of Oseltamivir Prophylaxis in Hematopoietic Stem Cell Transplant Recipients: A Retrospective Case-Control Study

D. Vu, Alexandra Peck, W. Garrett Nichols et al. · Clinical Infectious Diseases · 2007 · 84 citations · Full text

The reliability of diagnostic coding and laboratory data to identify tuberculosis and nontuberculous mycobacterial disease among rheumatoid arthritis patients using anti‐tumor necrosis factor therapy

Kevin Winthrop, Roger Baxter, Liyan Liu et al. · Pharmacoepidemiology and Drug Safety · 2010 · 81 citations · Full text

Initiation of Anti-TNF Therapy and the Risk of Optic Neuritis: From the Safety Assessment of Biologic ThERapy (SABER) Study

Kevin Winthrop, Lang Chen, Frederick W. Fraunfelder et al. · American Journal of Ophthalmology · 2012 · 67 citations · Full text

Rheumatology, Anti-tnf Therapy, Ocular Disease +7

Distinguishing Tuberculosis from Nontuberculous Mycobacteria Lung Disease, Oregon, USA

B. Kendall, Cara D Varley, Dongseok Choi et al. · Emerging infectious diseases · 2011 · 55 citations · Full text

Tuberculosis Prevention, Diagnosis, Pathology +16